ATE552027T1 - Minimierung von hämodynamischem kompromiss bei pacing nach einem mi - Google Patents

Minimierung von hämodynamischem kompromiss bei pacing nach einem mi

Info

Publication number
ATE552027T1
ATE552027T1 AT10167268T AT10167268T ATE552027T1 AT E552027 T1 ATE552027 T1 AT E552027T1 AT 10167268 T AT10167268 T AT 10167268T AT 10167268 T AT10167268 T AT 10167268T AT E552027 T1 ATE552027 T1 AT E552027T1
Authority
AT
Austria
Prior art keywords
pacing
post
hemodynamic compromise
minimizing
minimizing hemodynamic
Prior art date
Application number
AT10167268T
Other languages
German (de)
English (en)
Inventor
Joseph Pastore
Rodney Salo
Jesse W Hartley
Andrew P Kramer
Jeffrey Stahmann
Original Assignee
Cardiac Pacemakers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiac Pacemakers Inc filed Critical Cardiac Pacemakers Inc
Application granted granted Critical
Publication of ATE552027T1 publication Critical patent/ATE552027T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A61N1/36843—Bi-ventricular stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
    • A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
    • A61N1/36842—Multi-site stimulation in the same chamber

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT10167268T 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi ATE552027T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67833705P 2005-05-06 2005-05-06
US11/276,741 US7742813B2 (en) 2005-05-06 2006-03-13 Minimizing hemodynamic compromise during post-mi remodeling control pacing

Publications (1)

Publication Number Publication Date
ATE552027T1 true ATE552027T1 (de) 2012-04-15

Family

ID=37192407

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10167268T ATE552027T1 (de) 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi
AT06759144T ATE474621T1 (de) 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06759144T ATE474621T1 (de) 2005-05-06 2006-05-05 Minimierung von hämodynamischem kompromiss bei pacing nach einem mi

Country Status (6)

Country Link
US (2) US7742813B2 (enExample)
EP (2) EP2255844B1 (enExample)
JP (1) JP4980345B2 (enExample)
AT (2) ATE552027T1 (enExample)
DE (1) DE602006015647D1 (enExample)
WO (1) WO2006121845A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7742813B2 (en) 2005-05-06 2010-06-22 Cardiac Pacemakers, Inc. Minimizing hemodynamic compromise during post-mi remodeling control pacing
US7877140B2 (en) * 2005-09-06 2011-01-25 Cardiac Pacemakers, Inc. Pressure sensing for feedback control of post-MI remodeling control pacing
WO2010039501A1 (en) * 2008-10-03 2010-04-08 Cardiac Pacemakers, Inc. Methods and apparatuses for cardiac resynchronization therapy mode selection based on intrinsic conduction
EP2189111A1 (en) * 2008-11-21 2010-05-26 Pulsion Medical Systems AG Apparatus and method for determining a physiologic parameter
US8423141B2 (en) * 2009-01-30 2013-04-16 Medtronic, Inc. Pre-excitation stimulus timing based on mechanical event
US8886315B2 (en) * 2011-12-23 2014-11-11 Medtronic, Inc. Effectiveness of ventricular sense response in CRT

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190035A (en) * 1981-06-18 1993-03-02 Cardiac Pacemakers, Inc. Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiological demand
US5626620A (en) * 1995-02-21 1997-05-06 Medtronic, Inc. Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy
US6076015A (en) * 1998-02-27 2000-06-13 Cardiac Pacemakers, Inc. Rate adaptive cardiac rhythm management device using transthoracic impedance
US6640135B1 (en) * 2000-04-06 2003-10-28 Cardiac Pacemakers, Inc. Apparatus and method for spatially and temporally distributing cardiac electrical stimulation
US6823214B1 (en) * 2000-09-08 2004-11-23 Cardiac Pacemakers, Inc. Self-calibrating rate-adaptive pacemaker
US6628988B2 (en) * 2001-04-27 2003-09-30 Cardiac Pacemakers, Inc. Apparatus and method for reversal of myocardial remodeling with electrical stimulation
US7346394B2 (en) * 2001-04-27 2008-03-18 Cardiac Pacemakers, Inc. Cardiac stimulation at high ventricular wall stress areas
US6748271B2 (en) * 2001-07-27 2004-06-08 Cardiac Pacemakers, Inc. Method and system for treatment of neurocardiogenic syncope
US6973349B2 (en) 2001-12-05 2005-12-06 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US6965797B2 (en) * 2002-09-13 2005-11-15 Cardiac Pacemakers, Inc. Method and apparatus for assessing and treating myocardial wall stress
US7065405B2 (en) * 2002-11-15 2006-06-20 Cardiac Pacemakers, Inc. Stress reduction pacing mode for arrhythmia prevention
US20040230219A1 (en) * 2003-05-12 2004-11-18 Roucher Leo R. Anchoring, supporting and centering catheter system for treating chronic total occlusions
US20050055058A1 (en) * 2003-09-08 2005-03-10 Mower Morton M. Method and apparatus for intrachamber resynchronization
US7392084B2 (en) * 2003-09-23 2008-06-24 Cardiac Pacemakers, Inc. Demand-based cardiac function therapy
US7450988B2 (en) * 2004-06-04 2008-11-11 Cardiac Pacemakers, Inc. Method and apparatus for minimizing post-infarct ventricular remodeling
US7366567B2 (en) * 2005-03-23 2008-04-29 Cardiac Pacemakers, Inc. Method for treating myocardial infarction
US7404802B2 (en) * 2005-05-05 2008-07-29 Cardiac Pacemakers, Inc. Trending of systolic murmur intensity for monitoring cardiac disease with implantable device
US7742813B2 (en) 2005-05-06 2010-06-22 Cardiac Pacemakers, Inc. Minimizing hemodynamic compromise during post-mi remodeling control pacing

Also Published As

Publication number Publication date
US7742813B2 (en) 2010-06-22
EP1901802B1 (en) 2010-07-21
US20060287683A1 (en) 2006-12-21
EP2255844B1 (en) 2012-04-04
ATE474621T1 (de) 2010-08-15
US8731666B2 (en) 2014-05-20
WO2006121845A2 (en) 2006-11-16
DE602006015647D1 (de) 2010-09-02
EP2255844A1 (en) 2010-12-01
US20100256702A1 (en) 2010-10-07
EP1901802A2 (en) 2008-03-26
JP4980345B2 (ja) 2012-07-18
JP2008539896A (ja) 2008-11-20
WO2006121845A3 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
DE60226267D1 (de) Gerät zur minimierung des ventrikulären remodelling nach infarkt
EA200700058A1 (ru) Соединения, композиции и способы их использования
EP1744394A4 (en) WATER-FREE ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY THEREWITH
EA201000145A1 (ru) Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
ATE494923T1 (de) Hämodynamisch kontrolliertes anti-tachyarrhythmie-schrittmachersystem
ATE546044T1 (de) Verwendung von alkylcarbonsäureamiden als penetrationsförderer
CY1115731T1 (el) Παραγοντας αναστολης toy mic-1
ATE498423T1 (de) Verfahren zur schmerzlinderung in zusammenhang mit nervenstimulation
DE602005004022D1 (de) Intraokulare steroid-implantate mit verzögerter freisetzung über einen zeitraum von über 2 monaten
ATE510584T1 (de) Unterdrückung von hochfrequenz-pacing zur reduzierung von ischämischer erregbarkeit des myokards
ATE344087T1 (de) Bestimmung der relativen herzdepolarisation an verschiedenen stellen im herzen
DE602005008053D1 (de) Eine biomoleküle enthaltende suspensionsformulierung von erhöhter stabilität - freisetzbar über ein implantierbares hilfsmittel
ATE530224T1 (de) Gerät und verfahren zur optimierung von atrioventrikulären pacing-verzögerungsintervallen
NL930144I2 (nl) Door fosfinylalkanoyl gesubstitueerde prolinen.
ATE474621T1 (de) Minimierung von hämodynamischem kompromiss bei pacing nach einem mi
WO2016022536A3 (en) Inhibitors of myh7b and uses thereof
DE60304005D1 (de) Änderung von Ladeadressen von ausführbaren Programm-modulen
DE60009690D1 (de) Verfahren zur verbesserung der verarbeitungscharakteristika von gefüllten polyolefinen
ATE534295T1 (de) Biozide zusammensetzung und ähnliche verfahren
DE602005011428D1 (de) Batterieaufladeverfahren
DE60318819D1 (de) Hitzestabile mutanten von stärkebiosyntheseenzymen
DE602004005325D1 (de) Verwendung von polyanhydriden in antifouling-lacken sowie polyanhydride enthaltender antifouling-lack
ATE490772T1 (de) Tetrahydro-pyrroloä1,2-büisothiazol 1,1-dioxide als lfa-1 inhibitoren
ATE239497T1 (de) Verwendung von urodilatin zur behandlung chronischer niereninsuffizienz mit nierenrestfunktionen
ATE449600T1 (de) Verwendung von glycerin zur verbesserung der herzfunktion